08:53 AM EDT, 06/03/2025 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday as the Health Care Select Sector SPDR Fund (XLV) was down 0.1% and the iShares Biotechnology ETF (IBB) was slightly higher recently.

Beam Therapeutics ( BEAM ) shares were advancing by more than 2% after the company said the US Food and Drug Administration has granted orphan drug designation to BEAM-101, an investigational cell therapy for sickle cell disease.